SG11202007554TA - Dioxazoline compound, preparation method therefor, and uses thereof - Google Patents

Dioxazoline compound, preparation method therefor, and uses thereof

Info

Publication number
SG11202007554TA
SG11202007554TA SG11202007554TA SG11202007554TA SG11202007554TA SG 11202007554T A SG11202007554T A SG 11202007554TA SG 11202007554T A SG11202007554T A SG 11202007554TA SG 11202007554T A SG11202007554T A SG 11202007554TA SG 11202007554T A SG11202007554T A SG 11202007554TA
Authority
SG
Singapore
Prior art keywords
preparation
method therefor
dioxazoline compound
dioxazoline
compound
Prior art date
Application number
SG11202007554TA
Other languages
English (en)
Inventor
Qiang Zhang
Shannan Yu
Zhongxiang Wang
Shouye Feng
Yueming Sun
Yansheng Liu
Hongbo Zhang
Leifu Yang
Hailong Yang
Likai Zhou
Nanqiao Zheng
Chenming Hu
Zhanqiang Xu
Original Assignee
Beijing Scitech Mq Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/CN2018/076233 external-priority patent/WO2018153293A1/zh
Application filed by Beijing Scitech Mq Pharmaceuticals Ltd filed Critical Beijing Scitech Mq Pharmaceuticals Ltd
Priority claimed from PCT/CN2019/073260 external-priority patent/WO2019154133A1/zh
Publication of SG11202007554TA publication Critical patent/SG11202007554TA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SG11202007554TA 2017-02-27 2019-01-25 Dioxazoline compound, preparation method therefor, and uses thereof SG11202007554TA (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CN201710107756 2017-02-27
PCT/CN2018/076233 WO2018153293A1 (zh) 2017-02-27 2018-02-11 二噁烷并喹唑啉与二噁烷并喹啉类化合物及其制备方法与应用
CN201810983341.3A CN110156803A (zh) 2017-02-27 2018-08-27 二噁烷并喹啉类化合物及其制备方法与应用
PCT/CN2019/073260 WO2019154133A1 (zh) 2018-02-11 2019-01-25 二噁烷并喹啉类化合物及其制备方法与应用

Publications (1)

Publication Number Publication Date
SG11202007554TA true SG11202007554TA (en) 2020-09-29

Family

ID=63374400

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202007554TA SG11202007554TA (en) 2017-02-27 2019-01-25 Dioxazoline compound, preparation method therefor, and uses thereof

Country Status (5)

Country Link
CN (3) CN108503650B (zh)
AU (1) AU2019218187B2 (zh)
DK (1) DK3750893T3 (zh)
ES (1) ES2945573T3 (zh)
SG (1) SG11202007554TA (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11731946B2 (en) 2017-10-19 2023-08-22 The General Hospital Corporation Broad spectrum antivirulence, anti-persistence compounds
CN110156804B (zh) * 2018-02-11 2021-01-12 北京赛特明强医药科技有限公司 一种二噁烷并喹啉类化合物及其制备方法
CN111196814B (zh) * 2018-11-19 2022-12-06 北京赛特明强医药科技有限公司 芳环连二噁烷并喹唑啉或喹啉类化合物、组合物及其应用
CN111004257B (zh) * 2019-12-24 2021-06-29 武汉九州钰民医药科技有限公司 制备RET抑制剂Selpercatinib的方法
CN112939995A (zh) * 2021-02-02 2021-06-11 北京工业大学 二噁烷并喹唑啉衍生物制备方法
CN114957136A (zh) * 2021-02-24 2022-08-30 南京科默生物医药有限公司 一种用作vegfr抑制剂的抗肿瘤化合物及其用途
WO2024094016A1 (zh) * 2022-11-01 2024-05-10 北京赛特明强医药科技有限公司 一种二噁烷并喹啉类化合物的盐、其晶型以及它们的制备方法及应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2371383T3 (es) * 2003-09-26 2011-12-30 Exelixis, Inc. N-[3-fluoro-4-({6-(metiloxi)-7-[(3-morfolin-4-ilpropil)oxi]quinolin-4-il}oxi)fenil]-n'-(4-fluorofenil)ciclopropan-1,1-dicarboxamida para el tratamiento del cáncer.
US8664244B2 (en) * 2010-09-12 2014-03-04 Advenchen Pharmaceuticals, LLC Compounds as c-Met kinase inhibitors
WO2012044572A1 (en) * 2010-09-27 2012-04-05 Exelixis, Inc. Dual inhibitors of met and vegf for the treatment of castration- resistant prostate cancer and osteoblastic bone metastases
CN104530063B (zh) * 2015-01-13 2017-01-18 北京赛特明强医药科技有限公司 喹唑啉并杂环类化合物及其制备方法和作为用于治疗癌症的表皮生长因子受体抑制剂的应用
CN106279147A (zh) * 2015-05-21 2017-01-04 中国科学院上海药物研究所 一种吡啶并氮杂环化合物及其制备方法和用途
CN105837586B (zh) * 2015-12-14 2018-02-13 北京赛特明强医药科技有限公司 二噁烷并喹唑啉胺类化合物及其制备方法和作为表皮生长因子受体抑制剂的应用
CN105541798B (zh) * 2016-02-03 2018-01-23 中国人民解放军第二军医大学 具有抗肿瘤活性的喹啉类多靶点激酶抑制剂及其制备方法
WO2018153293A1 (zh) * 2017-02-27 2018-08-30 北京赛特明强医药科技有限公司 二噁烷并喹唑啉与二噁烷并喹啉类化合物及其制备方法与应用

Also Published As

Publication number Publication date
DK3750893T3 (da) 2023-05-08
CN111788207A (zh) 2020-10-16
CN111788207B (zh) 2021-03-23
CN108503650A (zh) 2018-09-07
CN108503650B (zh) 2021-02-12
CN110156803A (zh) 2019-08-23
ES2945573T3 (es) 2023-07-04
AU2019218187B2 (en) 2021-10-14
AU2019218187A1 (en) 2020-09-10

Similar Documents

Publication Publication Date Title
IL272089B1 (en) Compounds, preparations and methods
HUE062446T2 (hu) Vegyületek, készítmények és eljárások
EP3299369A4 (en) Pyrido-azaheterecydic compound and preparation method and use thereof
HK1247205A1 (zh) 烯丙基苯氧基環磷腈化合物及其製造方法
SG11202007554TA (en) Dioxazoline compound, preparation method therefor, and uses thereof
GB2557741B (en) Icariside compound, preperation method thereof, and application thereof
EP3246327A4 (en) 3-acetylenyl-pyrazole-pyrimidine derivative, and preparation method therefor and uses thereof
EP3372596A4 (en) METHOD FOR THE PRODUCTION OF TEDIZOLIDE, TEDIZOLIDE INTERMEDIATE PRODUCTION AND METHOD OF MANUFACTURING THEREOF
SG11202007521PA (en) Urea-substituted aromatic ring-linked dioxazoline compound, preparation method therefor, and uses thereof
HK1255559A1 (zh) Mg53突變體及其製備方法和用途
PT3552017T (pt) Compostos úteis como inibidores de ripk1
EP3715342A4 (en) COMPONENT CONTAINING FLUOROSULFONYL, INTERMEDIATE THEREOF, RELATED PREPARATION PROCESS AND CORRESPONDING USE
EP3112351A4 (en) Naphthylamide compound, preparation method and use thereof
HK1243437A1 (zh) 一類三肽化合物及其製備方法與應用
EP3447054A4 (en) CONNECTION AND MANUFACTURING METHOD THEREFOR, COMPOSITION AND APPLICATION THEREOF
EP3543248A4 (en) PHOSPHORESCENT COMPLEX OF PtAg2, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF
IL282817A (en) New material, production method, and its use
GB2564511B (en) Composition, method and use
GB201805016D0 (en) Composition, method and use
EP3581561A4 (en) BIARYL COMPOUND, MANUFACTURING METHOD AND USE THEREOF
GB201705124D0 (en) Composition, method and use
EP3392263A4 (en) POLYPEPTIDE COMPOUND, METHOD FOR PREPARING THE SAME, AND USE THEREOF
PL3750893T3 (pl) Związek dioksazoliny, sposób jego wytwarzania oraz jego zastosowania
PL3760633T3 (pl) Oksazynochinazolina i związek typu oksazynochinazoliny, sposób ich wytwarzania i ich zastosowania
EP3564215A4 (en) POLYHYDROXYPHTHALAZINONE COMPOUND, PRODUCTION METHOD THEREFOR AND USE THEREOF